Mónica Béquet-Romero

5PUBLICATIONS
11CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 27, 2026
Longitudinal Assessment of an 800 µg Dose of HEBERSaVax in Non-Human Primates over Six Months.

Camila Canaán-Haden, Isabel Gonzalez-Moya, Monica Bequet-Romero

|Apr 23, 2025
Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys.

Camila Canaán-Haden, Javier Sánchez-Ramírez, Rafael Martínez-Castillo

|Jun 24, 2022
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.

Ileanet Ávalos, Thailin Lao, Elsa María Rodríguez

|Apr 04, 2022
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF.

Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero

|Aug 21, 2019
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds.

Ariana García-Ojalvo, Jorge Berlanga Acosta, Alain Figueroa-Martínez

Pageof 1

Frequent Collaborators

3 joint publications

Yanelys Morera-Díaz

2 joint publications

Camila Canaán-Haden

2 joint publications

Isabel Gonzalez-Moya

2 joint publications

Alexei F Licea-Navarro